Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Schering-Plough presents new agents for cognitive disorders

April 2, 1998

Effects of MKC-242 on cholinergic neurons examined using in vivo microdialysis

April 1, 1998

MCI-225: neurochemical profile of a novel antidepressant

April 1, 1998

OPC-24439, a new sigma-receptor ligand, suppresses hippocampal neuronal activity

April 1, 1998

Synthelabo claims compounds with selective affinity for certain GABA-A receptors

April 1, 1998

NOS inhibitors claimed by Schering AG for CNS disorders

April 1, 1998

Zeneca in-licenses novel chiral anesthetic agent

April 1, 1998

Melatonin may be involved in the hypnotic activity of zaleplon

March 31, 1998

Sumitomo presents new NHE inhibitor with neuroprotective effects

March 31, 1998

Excitatory amino acid receptor antagonists related to PNQX reported at ACS

March 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...